Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin serum levels after implantation of gentamicin PMMA beads
NL-OMON35413Active, not recruiting
- Sponsor
- Ziekenhuisapotheek
- Start
- Mar 2009
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of gentamicin, sponsored by Ziekenhuisapotheek. Primary endpoint: Gentamicin serum level greater than 0.4 mg/L. Started Mar 2009; status: active, not recruiting.
02
Drugs
gentamicin
Beyond the preview
Go deeper on NL-OMON35413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35413.